Position in PFE
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$5,444,873
-$1,076,538 QoQ
Shares Held
226,116
-2.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.00%
of 13F equity value
Holder Rank
#575
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Raab & Moskowitz Asset Management LLC holds $28,665,612 across 9 Drug Manufacturers - General names. PFE ranks #4 (19.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
51,773 | $6,652,830 | |
| 2 | ABBV |
AbbVie Inc.
|
25,628 | $6,449,029 | |
| 3 | JNJ |
Johnson & Johnson
|
22,910 | $5,818,452 | |
| 4 | PFE |
Pfizer Inc
This page
|
226,116 | $5,444,873 | |
| 5 | LLY |
ELI LILLY & Co
|
1,809 | $2,169,769 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
16,300 | $939,206 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,144 | $523,552 | |
| 8 | SNY |
Sanofi
|
9,307 | $397,036 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,444,873 | 226,116 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $6,521,411 | 232,244 | Shares | Sole | 2026-05-21 | |
| 2025-12-31 | $6,000,003 | 240,964 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $7,156,669 | 280,874 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $6,886,680 | 284,104 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,400,724 | 292,057 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,576,092 | 285,567 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $7,499,337 | 259,134 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $6,685,457 | 238,937 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $4,341,210 | 156,440 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,850,576 | 133,747 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $4,373,895 | 131,863 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $4,641,413 | 126,538 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $5,207,467 | 127,634 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,575,834 | 128,334 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $5,522,643 | 126,203 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,990,334 | 133,327 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,834,416 | 132,015 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $8,019,698 | 135,812 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $5,902,606 | 137,238 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $5,401,064 | 137,923 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $5,026,477 | 138,738 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $5,116,111 | 138,987 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,137,627 | 139,990 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,725,776 | 144,519 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,699,011 | 143,965 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||